Does Nebivolol Prevent Contrast-Induced Nephropathy in Humans?


Creative Commons License

Gunebakmaz O. , KAYA M., Koc F., Akpek M. , Kasapkara A., İNANÇ M. T. , ...More

CLINICAL CARDIOLOGY, vol.35, no.4, pp.250-254, 2012 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 35 Issue: 4
  • Publication Date: 2012
  • Doi Number: 10.1002/clc.21013
  • Title of Journal : CLINICAL CARDIOLOGY
  • Page Numbers: pp.250-254

Abstract

Background: An experimental study showed that nebivolol is an effective agent in contrast-induced nephropathy (CIN) prophylaxis.